Home Page

DUBLIN, Sep. 03, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/pqvrgz/diabetes_care) has announced the addition of the "Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020" report to their offering.

The BRIC diabetes care devices market is estimated to be valued at USD 1.7 Billion in 2015 and is poised to reach USD 2.3 Billion by 2020, growing at a CAGR of 6.3% during the forecast period. Increasing diabetic population, growing research on diabetes, and lifestyle changes (driving the prevalence of diabetes among urban population) are the main factors driving the growth of this market. Rising obese population associated with diabetes and increasing international collaborations are further expected to contribute to the growth of this market. On the other hand, high cost of devices, emergence of alternative therapies, disparity in reimbursement, and lack of awareness may restrict the growth of this market to a certain extent.

China dominated this market, with more than 50% share in 2014. Growth in this market is mainly driven by the increasing number of diabetic patients, increasing number of international research collaborations, government initiatives, and expansion of global players in the country. The diabetes care devices market in China is characterized by the presence of numerous local players offering various diabetes care devices for the domestic market. However, this market is expected to witness a sluggish growth rate as it remains highly penetrated. India, on the other hand, is expected to witness the highest growth rate during the forecast period. The rising diabetic population, rapid industrialization and urbanization, and growing research on diabetes and its management are the key factors propelling the growth of this market.

The BRIC diabetes care devices market is consolidated in nature, with the top four players occupying around 45 - 55% of the market share. Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), and Abbott Laboratories (U.S.) are the top four players in this market. These companies have been adopting strategies such as new product launches and collaborations and agreements to sustain and maintain their market shares in this market.

Scope of the Report

Diabetes is a group of metabolic disorders, characterized by high blood glucose levels due to either inadequate insulin production or insulin resistance. Diabetes care devices are used to manage blood glucose levels.

Diabetes Care Devices Market, by Type:

Blood Glucose Monitoring Devices
- Testing Strips
- Self-monitoring Blood Glucose Meters
- Lancets
- Continuous Glucose Monitors
- Others

Insulin Delivery Devices
- Insulin Syringes
- Insulin Pens
- Insulin Pumps
- Insulin Jet Injectors

Companies Mentioned

- Abbott Laboratories
- Acon Laboratories, Inc.
- Arkray, Inc.
- Bayer AG
- Becton, Dickinson and Company
- Dexcom, Inc.
- Johnson & Johnson
- Medtronic PLC
- Novo Nordisk A/S
- Roche Diagnostics Limited
- Sanofi
- Terumo Corporation
- Ypsomed AG

For more information visit http://www.researchandmarkets.com/research/pqvrgz/diabetes_care

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets